FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...